View of Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits | Diabetes, Obesity, Metabolic Syndrome

← Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits